5HT1A and 5HT2A receptor genes in treatment response phenotypes in major depressive disorder

International Clinical Psychopharmacology

Volumn 25, Issue 4, 2010, Pages 228-231

  Noro, Magali ^a   Antonijevic, Irina ^b   Forray, Carlos ^b   Kasper, Siegfried ^c   Kocabas, Neslihan Aygun ^a,d   Lecrubier, Yves ^e   Linotte, Sylvie ^a   Mendlewicz, Julien ^a   Montgomery, Stuart ^f   Snyder, Lenore ^b   Souery, Daniel ^a   Verbanck, Paul ^a   Zohar, Joseph ^g   Massat, Isabelle ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b LUNDBECK RESEARCH USA   (United States)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d GAZI UNIVERSITY   (Turkey)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^g SHEBA MEDICAL CENTER   (Israel)

Author keywords

Antidepressant treatment; Major depressive disorder; Phenotype; Serotonin receptor; Single nucleotide polymorphism; Treatment resistant depression

Indexed keywords

SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DRUG RESISTANCE; GENE FREQUENCY; GENOTYPE; HUMANS; PHARMACOGENETICS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; RECEPTOR, SEROTONIN, 5-HT1A; RECEPTOR, SEROTONIN, 5-HT2A; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77953723097     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/YIC.0b013e328338bcf4     Document Type: Article

References (30)

1. Anttila S, Huuhka K, Huuhka M, Rontu R, Hurme M, Leinonen E, et al. (2007a). Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. J Neural Transm 114:1065-1068.
2. Anttila S, Huuhka K, Huuhka M, Rontu R, Mattila KM, Leinonen E, et al. (2007b). Interaction between TPH1 and GNB3 genotypes and electroconvulsive therapy in major depression. J Neural Transm 114:461-468.
3. Arias B, Catalan R, Gasto C, Gutierrez B, Fananas L (2005). Evidence for a combined genetic effect of the 5-HT1A receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram. J Psychopharmacol 19:166-172.
4. Baune BT, Hohoff C, Roehrs T, Deckert J, Arolt V, Domschke K (2008). Serotonin receptor 1A 1019C/G variant: Impact on antidepressant pharmacoresponse in melancholic depression? Neurosci Lett 436:111-115.
5. Chen K, Yang W, Grimsby J, Shih JC (1992). The human 5-HT2 receptor is encoded by a multiple intron-exon gene. Brain Res Mol Brain Res 14:20-26.
6. Choi MJ, Kang RH, Ham BJ, Jeong HY, Lee MS (2005). Serotonin receptor 2A gene polymorphism (-1438A/G) and short-term treatment response to citalopram. Neuropsychobiology 52:155-162.
7. Hong CJ, Chen TJ, Yu YW, Tsai SJ (2006). Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder. Pharmacogenomics J 6:27-33.
8. Huuhka K, Kampman O, Anttila S, Huuhka M, Rontu R, Mattila KM, et al. (2008). RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder. Neurosci Lett 437:25-28.
9. Illi A, Setälä-Soikkeli E, Viikki M, Poutanen O, Huhtala H, Mononen N, et al. (2009). 5-HTR1A, 5-HTR2A, 5-HTR6, TPH1 and TPH2 polymorphisms and major depression. Neuroreport 20:1125-1128.
10. Kang RH, Choi MJ, Paik JW, Hahn SW, Lee MS (2007). Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression. Int J Psychiatry Med 37:315-329.
11. Kato M, Fukuda T, Wakeno M, Fukuda K, Okugawa G, Ikenaga Y, et al. (2006). Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese patients. Neuropsychobiology 53:186-195.
12. Kato M, Zanardi R, Rossini D, De Ronchi D, Okugawa G, Kinoshita T, et al. (2009a). 5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients. Psychiatry Res 167:97-105.
13. Kato M, Fukuda T, Wakeno M, Okugawa G, Takekita Y, Watanabe S, et al. (2009b). Effect of 5-HT1A gene polymorphisms on antidepressant response in major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 150B:115-123.
14. Kishida I, Aklillu E, Kawanishi C, Bertilsson L, Agren H (2007). Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression. Neuropsychopharmacology 32:2143-2151.
15. Kobilka BK, Frielle T, Collins S, Yang-Feng T, Kobilka TS, Francke U, et al. (1987). An intronless gene encoding a potential member of the family of receptors coupled to guanine nucleotide regulatory proteins. Nature 329:75-79.
16. Lemonde S, Du L, Bakish D, Hrdina P, Albert PR (2004). Association of the C(1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacology 7:501-506.
17. Levin GM, Bowles TM, Ehret MJ, Langaee T, Tan JY, Johnson JA, et al. (2007). Assessment of human serotonin 1A receptor polymorphisms and SSRI responsiveness. Mol Diagn Ther 11:155-160.
18. McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, et al. (2006). Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 78:804-814.
19. Minov C, Baghai TC, Schüle C, Zwanzger P, Schwarz MJ, Zill P, et al. (2001). Serotonin-2A-receptor and-transporter polymorphisms: lack of association in patients with major depression. Neurosci Lett 303:119-122.
20. Neumeister A, Young T, Stastny J (2004). Implications of genetic research on the role of the serotonin in depression: emphasis on the serotonin type 1A receptor and the serotonin transporter. Psychopharmacology 174:512-524.
21. Parsey RV, Olvet DM, Oquendo MA, Huang YY, Ogden RT, Mann JJ (2006). Higher 5-HT(1A) receptor binding potential during a major depressive episode predicts poor treatment response: Preliminary data from a naturalistic study. Neuropsychopharmacology 31:1745-1749.
22. Perlis RH, Fijal B, Adams DH, Sutton VK, Trivedi MH, Houston JP (2009). Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder. Biol Psychiatry 65:785-791.
23. Sato K, Yoshida K, Takahashi H, Ito K, Kamata M, Higuchi H, et al. (2002). Association between-1438G/A promoter polymorphism in the 5-HT(2A) receptor gene and fluvoxamine response in Japanese patients with major depressive disorder. Neuropsychobiology 46:136-140.
24. Serretti A, Lorenzi C, Lilli R, Smeraldi E (2000). Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders. J Psychiatr Res 34:89-98.
25. Serretti A, Artioli P, Lorenzi C, Pirovano A, Tubazio V, Zanardi R (2004). The C(-1019)G polymorphism of the 5-HT1A gene promoter and antidepressant response in mood disorders: preliminary findings. Int J Neuropsychopharmacol 7:453-460.
26. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, et al. (2007). Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. J Clin Psychiatry 68:1062-1070.
27. Sparkes RS, Lan N, Klisak I, Mohandas T, Diep A, Kojis T, et al. (1991). Assignment of a serotonin 5HT-2 receptor gene (HTR2) to human chromosome 13q14-q21 and Mouse chromosome 14. Genomics 9:461-465.
28. Wilkie MJ, Smith G, Day RK, Matthews K, Smith D, Blackwood D, et al. (2009). Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy. Pharmacogenomics J 9:61-70.
29. Wu S, Comings DE (1999). A common C-1018G polymorphism in the human 5-HT1A receptor gene. Psychiatr Genet 9:105-106.
30. Yu YW, Tsai SJ, Liou YJ, Hong CJ, Chen TJ (2006). Association study of two serotonin 1A receptor gene polymorphisms and fluoxetine treatment response in Chinese major depressive disorders. Eur Neuropsychopharmacol 16: 498-503.